loadpatents
name:-0.20797204971313
name:-0.020150899887085
name:-0.011674880981445
Wittekind; Michael Patent Filings

Wittekind; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wittekind; Michael.The latest application filed is for "methods for characterizing and engineering protein-protein interactions".

Company Profile
10.23.37
  • Wittekind; Michael - Bainbridge Island WA
  • Wittekind; Michael - Seattle WA
  • Wittekind; Michael - Yonkers NY
  • WITTEKIND; Michael - NE Bainbridge Island WA
  • Wittekind; Michael - New Canaan CT
  • Wittekind; Michael - Doylestown PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Lysin polypeptides active against Gram-negative bacteria
Grant 11,413,334 - Schuch , et al. August 16, 2
2022-08-16
Methods For Characterizing And Engineering Protein-protein Interactions
App 20220251543 - Younger; David ;   et al.
2022-08-11
Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
Grant 11,357,833 - Wittekind , et al. June 14, 2
2022-06-14
Antibodies Useful In Passive Influenza Immunization, And Compositions, Combinations And Methods For Use Thereof
App 20220111049 - Estelles; Angeles ;   et al.
2022-04-14
Methods For Characterizing And Engineering Protein-protein Interactions
App 20220107326 - Younger; David ;   et al.
2022-04-07
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
Grant 11,246,928 - Estelles , et al. February 15, 2
2022-02-15
Bacteriophage Lysin And Antibiotic Combinations Against Gram Positive Bacteria
App 20210128696 - SCHUCH; Raymond ;   et al.
2021-05-06
Libraries of modified fibronectin type III tenth domain-containing polypeptides
Grant 10,995,131 - Chen , et al. May 4, 2
2021-05-04
MODIFIED PlySs2 LYSINS AND USES THEREOF
App 20210032294 - SCHUCH; Raymond ;   et al.
2021-02-04
Bacteriophage Lysin And Antibiotic Combinations Against Gram Positive Bacteria
App 20210008175 - SCHUCH; Raymond ;   et al.
2021-01-14
Lysin Polypeptides Active Against Gram-negative Bacteria
App 20200376096 - SCHUCH; Raymond ;   et al.
2020-12-03
Bacteriophage lysin and antibiotic combinations against gram positive bacteria
Grant 10,813,983 - Schuch , et al. October 27, 2
2020-10-27
Lysin polypeptides active against Gram-negative bacteria
Grant 10,744,189 - Schuch , et al. A
2020-08-18
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
Grant 10,639,370 - Estelles , et al.
2020-05-05
Antibodies Useful In Passive Influenza Immunization, And Compositions, Combinations And Methods For Use Thereof
App 20200054749 - Estelles; Angeles ;   et al.
2020-02-20
Biofilm Prevention, Disruption And Treatment With Bacteriophage Lysin
App 20190387745 - SCHUCH; Raymond ;   et al.
2019-12-26
Use Of Lysin To Restore/augment Antibacterial Activity In The Presence Of Pulmonary Surfactant Of Antibiotics Inhibited Thereby
App 20190290672 - WITTEKIND; Michael ;   et al.
2019-09-26
Lysin Polypeptides Active Against Gram-negative Bacteria
App 20190070269 - SCHUCH; Raymond ;   et al.
2019-03-07
Bacteriophage Lysin And Antibiotic Combinations Against Gram Positive Bacteria
App 20180221456 - SCHUCH; Raymond ;   et al.
2018-08-09
Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
App 20180162926 - CHEN; Yan ;   et al.
2018-06-14
Bacteriophage lysin and antibiotic combinations against gram positive bacteria
Grant 9,889,181 - Schuch , et al. February 13, 2
2018-02-13
Inhibitors of type 2 vascular endothelial growth factor receptors
Grant 9,862,758 - Chen , et al. January 9, 2
2018-01-09
Composition And Methods Based On Neutralizing Antibodies Delivered Intranasally For Enhanced Therapeutic Efficacy
App 20170334974 - WITTEKIND; Michael ;   et al.
2017-11-23
Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
Grant 9,718,875 - Wittekind , et al. August 1, 2
2017-08-01
Antibodies Useful In Passive Influenza Immunization, And Compositions, Combinations And Methods For Use Thereof
App 20170189529 - Estelles; Angeles ;   et al.
2017-07-06
Biofilm Prevention, Disruption And Treatment With Bacteriophage Lysin
App 20170127683 - Schuch; Raymond ;   et al.
2017-05-11
Composition And Methods Based On Neutralizing Antibodies Delivered Intranasally For Enhanced Therapeutic Efficacy
App 20170002062 - Wittekind; Michael ;   et al.
2017-01-05
Biofilm prevention, disruption and treatment with bacteriophage lysin
Grant 9,499,594 - Schuch , et al. November 22, 2
2016-11-22
Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
App 20160297869 - CHEN; Yan ;   et al.
2016-10-13
Inhibitors of type 2 vascular endothelial growth factor receptors
Grant 9,328,157 - Chen , et al. May 3, 2
2016-05-03
Composition And Methods Based On Neutralizing Antibodies Delivered Intranasally For Enhanced Therapeutic Efficacy
App 20160083456 - WITTEKIND; Michael ;   et al.
2016-03-24
Bacteriophage Lysin And Antibiotic Combinations Against Gram Positive Bacteria
App 20150290299 - Schuch; Raymond ;   et al.
2015-10-15
Human LCAT Antigen Binding Proteins and Their Use in Therapy
App 20150284471 - Meininger; David ;   et al.
2015-10-08
Biofilm Prevention, Disruption And Treatment With Bacteriophage Lysin
App 20150111813 - Schuch; Raymond ;   et al.
2015-04-23
Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
App 20140179896 - CHEN; Yan ;   et al.
2014-06-26
Host Cell For Making Antibody Fc-heterodimeric Molecules Using Electrostatic Steering Effects
App 20140024111 - KANNAN; Gunasekaran ;   et al.
2014-01-23
Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides
Grant 8,609,613 - Chen , et al. December 17, 2
2013-12-17
Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
Grant 8,592,562 - Kannan , et al. November 26, 2
2013-11-26
Bacteriophage Lysin And Antibiotic Combinations Against Gram Positive Bacteria
App 20130302306 - Schuch; Raymond ;   et al.
2013-11-14
Pre-Ligand assembly domain of the IL-17 receptor
App 20130302886 - GAFFEN; Sarah L. ;   et al.
2013-11-14
Pre-ligand assembly domain of the IL-17 receptor
Grant 8,460,647 - Gaffen , et al. June 11, 2
2013-06-11
Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors
Grant 8,324,362 - Chen , et al. December 4, 2
2012-12-04
Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
App 20120283184 - Chen; Yan ;   et al.
2012-11-08
Methods for generating monovalent IgG
Grant 8,193,322 - Yan , et al. June 5, 2
2012-06-05
Identification And Method For Using The Pre-ligand Assembly Domain Of The Il-17 Receptor
App 20120009190 - Gaffen; Sarah L. ;   et al.
2012-01-12
Inhibitors of type 2 vascular endothelial growth factor receptors
Grant 7,858,739 - Chen , et al. December 28, 2
2010-12-28
Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
App 20100310549 - CHEN; YAN ;   et al.
2010-12-09
Pharmacokinetic modulation and compositions for modified FN3 polypeptides
Grant 7,847,062 - Chen , et al. December 7, 2
2010-12-07
Method For Making Antibody Fc-heterodimeric Molecules Using Electrostatic Steering Effects
App 20100286374 - Kannan; Gunasekaran ;   et al.
2010-11-11
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
App 20080220049 - Chen; Yan ;   et al.
2008-09-11
Methods for generating monovalent IgG
App 20070105199 - Yan; Wei ;   et al.
2007-05-10
Modified forms of hepatitis C NS3 protease for facilitating inhibitor screening and structural studies of protease:inhibitor complexes
Grant 6,800,456 - Wittekind , et al. October 5, 2
2004-10-05
Modified forms of hepatitis C NS3 protease for facilitating inhibitor screening and structural studies of protease:inhibitor complexes
App 20020106642 - Wittekind, Michael ;   et al.
2002-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed